The state of California has passed a new law requiring pharmaceutical companies to notify it of price rises in advance – and offer an explanation of why they are necessary.
A new report from the Social Market Foundation think tank argues that the UK’s National Health Service should switch to paying for medicines based on patient outcomes.
Facing opposition and delay to healthcare reform in Congress, Trump aims to pass an executive order to address drug pricing - but it contains the now familiar contradictions